Table 1.
Demographic, biochemical, and clinical characteristics of all obese subjects recruited in the study, subdivided into the two groups with or without metabolic syndrome, who underwent the 3-week BWRP.
| All Obese Subjects | ||||||
|---|---|---|---|---|---|---|
| Parameter | Without Metabolic Syndrome | With Metabolic Syndrome | ||||
| Before | After | Δ (%) | Before | After | Δ (%) | |
| N. | 726 | - | - | 1196 | - | - |
| Age (yr) | 46.1 ± 15.3 a | - | - | 53.4 ± 12.6 | - | - |
| BMI (kg/m2) | 42.5 ± 5.3 a | 40.7 ± 5.1 | −4.4 ± 1.4 | 43.8 ± 6.6 | 41.9 ± 6.4 b | −4.3 ± 1.6 |
| TOT-CHOL (mg/dL) | 191.2 ± 35.5 a | 168.0 ± 31.1 b | −11.4 ± 11.4 a | 198.0 ± 37.9 | 170.3 ± 35.0 b | −13.1 ± 14.0 |
| HDL-CHOL (mg/dL) | 56.0 ± 12.2 a | 46.5 ± 10.4 b | −16.0 ± 12.2 a | 45.6 ± 11.4 | 39.8 ± 9.3 b | −11.6 ± 13.3 |
| Glucose (mg/dL) | 83.5 ± 11.9 a | - | - | 108.0 ± 36.9 | - | - |
| Triglycerides (mg/dL) | 99.9 ± 32.3 a | - | - | 159.4 ± 70.5 | - | - |
| DBP (mmHg) | 76.2 ± 7.9 a | 73.8 ± 6.4 b | −2.3±11.3 | 77.6 ± 7.7 | 74.8 ± 6.6 b | −2.8 ± 11.3 |
| SBP (mmHg) | 125.5 ± 13.8 a | 119.9 ± 9.0 b | −3.7 ± 9.0 a | 130.4 ± 13.6 | 122.2 ± 9.7 b | −5.6 ± 9.6 |
| CHD score | 3.1 ± 5.4 a | 3.3 ± 5.6 | 6.6 ± 102.3 a | 8.5 ± 4.8 | 7.9 ± 5.1 b | −7.7 ± 79.2 |
| FSS | 34.5 ± 12.7 a | 26.9 ± 11.5 b | −20.8 ± 20.2 | 38.3 ± 12.9 | 29.8 ± 11.8 b | −20.8 ± 19.9 |
| SCT (s) | 5.7 ± 1.8 a | 5.4 ± 1.8 b | −5.5 ± 6.1 | 6.4 ± 1.9 | 6.1 ± 1.9 b | −5.2 ± 5.2 |
Abbreviations: BMI, body mass index; TOT-CHOL, total cholesterol; HDL-chol, high-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; CHD, coronary heart disease; FSS, fatigue severity score; SCT, stair climbing test. a: p < 0.05 vs. group with metabolic syndrome; b: p < 0.05 vs. the corresponding group before BWRP.